Ranked by reported Q2 2026 13F market value
Share of total reported institutional value in CHRS held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | Timothy G. Youngquist 2020 Irrevocable Trust | 13.1M | $18.3M | β | 10.661% | 2.08% |
| 2 | BlackRock, Inc. | 12.0M | $16.8M | +15.8% | 9.806% | 0.00% |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 5.9M | $8.3M | +9.1% | 4.860% | 0.00% |
| 4 | GEODE CAPITAL MANAGEMENT, LLC | 3.7M | $5.2M | +18.1% | 3.011% | 0.00% |
| 5 | Samsara BioCapital, LLC | 3.4M | $4.8M | 0.0% | 2.801% | 0.39% |
| 6 | Kohlberg Kravis Roberts & Co. L.P. | 3.0M | $4.2M | 0.0% | 2.480% | 0.07% |
| 7 | STATE STREET CORP | 2.4M | $3.3M | +2.4% | 1.946% | 0.00% |
| 8 | TWO SIGMA INVESTMENTS, LP | 2.3M | $3.2M | -1.8% | 1.846% | 0.00% |
| 9 | CM Management, LLC | 2.1M | $2.9M | 0.0% | 1.716% | 1.87% |
| 10 | Alyeska Investment Group, L.P. | 1.7M | $2.4M | -23.0% | 1.416% | 0.01% |
| 11 | Hudson Bay Capital Management LP | 1.7M | $2.4M | -0.7% | 1.383% | 0.01% |
| 12 | AQR CAPITAL MANAGEMENT LLC | 1.3M | $1.9M | +10.3% | 1.087% | 0.00% |
| 13 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.2M | $1.7M | +6.2% | 1.003% | 0.00% |
| 14 | PANAGORA ASSET MANAGEMENT INC | 1.1M | $1.6M | -22.1% | 0.929% | 0.00% |
| 15 | NORTHERN TRUST CORP | 1.1M | $1.6M | +23.6% | 0.923% | 0.00% |
| 16 | VANGUARD FIDUCIARY TRUST CO | 1.0M | $1.4M | +7.0% | 0.830% | 0.00% |
| 17 | NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 900K | $1.3M | 0.0% | 0.735% | 0.00% |
| 18 | VANGUARD PORTFOLIO MANAGEMENT LLC | 883K | $1.2M | +46.1% | 0.722% | 0.00% |
| 19 | UBS Group AG | 760K | $1.1M | +39.0% | 0.621% | 0.00% |
| 20 | GOLDMAN SACHS GROUP INC | 602K | $843K | -13.5% | 0.492% | 0.00% |
| 21 | RENAISSANCE TECHNOLOGIES LLC | 563K | $788K | +69.8% | 0.460% | 0.00% |
| 22 | STRS OHIO | 396K | $554K | +22.1% | 0.323% | 0.00% |
| 23 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 391K | $547K | -11.3% | 0.319% | 0.01% |
| 24 | Invesco Ltd. | 354K | $495K | +5.5% | 0.289% | 0.00% |
| 25 | Bank of New York Mellon Corp | 320K | $448K | +12.2% | 0.261% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). β% of Fundβ shows how much of that investorβs total 13F portfolio is invested in CHRS β a direct measure of their conviction.
Filings activity in CHRS during Q2 2026, grouped by how each filer changed its position.
8 quarters of 13F filings Β· Ξ columns show change vs prior quarter
| Quarter | Inst. Holders | Ξ Holders | Ownership % | Ξ Ownership | Total 13F Value | Ξ Value |
|---|---|---|---|---|---|---|
| Q2 2026 | 148 | 6.3% | 57.60% | +8.95 pp | $95M | 1.1% |
| Q1 2026 | 158 | +23% | 48.65% | 4.79 pp | $96M | +39% |
| Q4 2025 | 128 | +15% | 53.44% | 3.10 pp | $69M | 16% |
| Q3 2025 | 111 | +0.0% | 56.54% | 3.71 pp | $82M | +112% |
| Q2 2025 | 111 | 5.9% | 60.25% | 7.42 pp | $39M | 20% |
| Q1 2025 | 118 | 4.1% | 67.67% | 5.63 pp | $48M | 46% |
| Q4 2024 | 123 | 3.9% | 73.30% | 126.69 pp | $89M | 72% |
| Q3 2024 | 128 | β | 199.99% | β | $313M | β |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Ξ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying CHRS stock.
Based on Q2 2026 13F filings, institutional ownership of Coherus Oncology, Inc. stands at 57.6%, held across 148 reporting institutions.
Timothy G. Youngquist 2020 Irrevocable Trust is the largest reported institutional holder of CHRS, with approximately 13,050,623 shares worth $0.02B as of Q2 2026.
Yes β 2 widely-followed marquee investors appear among the top 25 institutional holders of CHRS, including TWO SIGMA INVESTMENTS, LP, RENAISSANCE TECHNOLOGIES LLC.
Our composite Smart Money Score for CHRS is 55 out of 100 (Neutral). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
9 institutions opened new positions in CHRS during Q2 2026, while 20 fully exited. 34 added to existing positions and 101 trimmed.
CHRS institutional ownership rose by 8.95 percentage points quarter-over-quarter, with a net change of -10 holders.
The top 10 institutions account for 73.1% of all reported 13F value in CHRS, and the top 25 account for 91.8%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
Coherus Oncology, Inc. (CHRS) Institutional Ownership